Skip Nav Destination
Issues
Journal Name Change
Former title: Haemostasis.
Pathophysiology of Haemostasis and Thrombosis 2002, Vol. 32, No. 2
Original Paper
Common C677T Polymorphism of the Methylenetetrahydrofolate Reductase Gene and the Risk of Venous Thromboembolism: Meta-Analysis of 31 Studies
Pathophysiology of Haemostasis and Thrombosis (2002) 32 (2): 51–58.
https://doi.org/10.1159/000065076
Home Treatment of Deep Vein Thrombosis: An Out-Patient Treatment Model with Once-Daily Injection of Low-Molecular-Weight Heparin (Tinzaparin) in 555 Patients
Leif Lapidus; Jens Börretzen; Martin Fahlén; Hans Grönlund Thomsen; Sverker Hasselblom; Lars Larson; Henrik Nordström; Lennart Stigendal; Lotte Waller
Pathophysiology of Haemostasis and Thrombosis (2002) 32 (2): 59–66.
https://doi.org/10.1159/000065077
Effects of a Long-Term Pharmacological Interruption of the Renin-Angiotensin System on the Fibrinolytic System in Essential Hypertension
Pathophysiology of Haemostasis and Thrombosis (2002) 32 (2): 67–75.
https://doi.org/10.1159/000065078
Screening for Cancer in Patients with Idiopathic Venous Thromboembolism: The Clinical Practice
Pathophysiology of Haemostasis and Thrombosis (2002) 32 (2): 76–79.
https://doi.org/10.1159/000065079
Plasma Tissue Plasminogen Activator and Plasminogen Activator Inhibitor-1 Levels in Acute Myocardial Infarction
Pathophysiology of Haemostasis and Thrombosis (2002) 32 (2): 80–84.
https://doi.org/10.1159/000065080
Modulation of Bcl-2 Family Proteins in Primary Endothelial Cells during Apoptosis
Pathophysiology of Haemostasis and Thrombosis (2002) 32 (2): 85–91.
https://doi.org/10.1159/000065081
Platelets and Anticoagulant Capacity in Patients with Inflammatory Bowel Disease
Torben Bjerregaard Larsen; Jens Nederby Nielsen; Lisbeth Fredholm; Erik D. Lund; Ivan Brandslund; Pia Munkholm; Henrik Hey
Pathophysiology of Haemostasis and Thrombosis (2002) 32 (2): 92–96.
https://doi.org/10.1159/000065082
